Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Molecular and Cellular Biochemistry|November 27, 2012
TRAIL induces autophagic protein cleavage through caspase activation in melanoma cell lines under arginine deprivationMin You, Niramol Savaraj, Macus T Kuo, et al.
World Journal of Surgery|August 14, 2019
Hypercoagulability After Resection of Thoracic Malignancy: A Prospective EvaluationMichelle B Mulder, Kenneth G Proctor, Evan J Valle, et al.
The Annals of Thoracic Surgery|October 1, 2011
Pulmonary resection for metastatic adrenocortical carcinoma: the National Cancer Institute experienceClinton D Kemp, R Taylor Ripley, Aarti Mathur, et al.
Biochemical and Biophysical Research Communications|March 16, 2010
The combination of ADI-PEG20 and TRAIL effectively increases cell death in melanoma cell linesMin You, Niramol Savaraj, Medhi Wangpaichitr, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 5, 2006
Gossypol, a phytochemical with BH3-mimetic property, sensitizes cultured thoracic cancer cells to Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligandWen-Shuz Yeow, Aris Baras, Alex Chua, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 4, 2005
The selective epidermal growth factor receptor tyrosine kinase inhibitor PD153035 suppresses expression of prometastasis phenotypes in malignant pleural mesothelioma cells in vitroGeorge W Cole, Annette M Alleva, Rishindra M Reddy, et al.
Molecular Cancer Therapeutics|December 19, 2006
Enhancement of Apo2L/TRAIL-mediated cytotoxicity in esophageal cancer cells by cisplatinWilson S Tsai, Wen-Shuz Yeow, Alex Chua, et al.
Redox Biology|January 15, 2021
OGG1 co-inhibition antagonizes the tumor-inhibitory effects of targeting MTH1Ling Zhang, Laura Misiara, Govindi J Samaranayake, et al.
Anticancer Research|April 20, 2006
Suppression of pro-metastasis phenotypes expression in malignant pleural mesothelioma by the PI3K inhibitor LY294002 or the MEK inhibitor UO126George W Cole, Annette M Alleva, Jing T Zuo, et al.
JAMA Network Open|March 23, 2023
Disparities in Survival Due to Social Determinants of Health and Access to Treatment in US Patients With Operable Malignant Pleural MesotheliomaAhmed Alnajar, Samuel A Kareff, Syed S Razi, et al.
Pageof 10